FROG Insider: CFO Disposes of 16,445 Shares via 10b5-1
Rhea-AI Filing Summary
Eduard Grabscheid, Chief Financial Officer of JFrog Ltd. (FROG), reported insider sales executed under a Rule 10b5-1 trading plan. On 08/18/2025 the reporting person sold a total of 16,445 ordinary shares in two transactions: 15,654 shares at a weighted average price of $44.46 and 791 shares at $45. After these disposals, the filing shows beneficial ownership of 144,233 shares following the larger sale and 143,442 shares following the smaller sale. The Form 4 notes the 10b5-1 plan was adopted May 16, 2025, and the report was signed by a representative under power of attorney on 08/20/2025. The filing asserts the seller will provide transaction-level price and quantity details to the SEC or other requestors.
Positive
- Sales were executed under a documented Rule 10b5-1 trading plan, which indicates pre-planned dispositions rather than ad-hoc insider trading
- Filing discloses weighted-average sale price ($44.46 for the larger block) and commits to provide per-trade details on request, supporting transparency
- Form 4 identifies reporting person and officer role (CFO), meeting Section 16 disclosure requirements
Negative
- Insider holdings decreased by 16,445 shares (15,654 + 791), reducing the CFO's beneficial ownership to 143,442 shares after the reported transactions
- Form does not include per-trade breakdown in the filing itself; specific quantities at each price are available only upon request
Insights
TL;DR: CFO sold 16,445 shares under a 10b5-1 plan; proceeds determined by reported weighted-average prices.
The Form 4 documents routine insider sales by the CFO executed under a pre-established Rule 10b5-1 trading plan adopted May 16, 2025. The filing provides aggregate share counts and weighted-average prices ($44.46 and $45) and discloses remaining beneficial ownership after each reported disposal (144,233 and 143,442 shares). For investors, these are non-discretionary plan sales rather than ad-hoc dispositions, and the filer has committed to provide transaction-level breakdowns on request. No derivative or other compensatory transactions are reported.
TL;DR: Disclosure aligns with Section 16 reporting and documents use of a 10b5-1 plan; signature by POA is noted.
The filing complies with Section 16 format: it identifies the reporting person as an officer (CFO), specifies the 10b5-1 plan adoption date (May 16, 2025), and reports sales with post-transaction beneficial ownership. The Form 4 is signed by a power-of-attorney designee (Shanti Ariker) dated 08/20/2025, which is an accepted practice when authorized. The filing offers to supply per-trade quantities and prices to regulators or shareholders upon request, supporting transparency. There are no disclosures here of option exercises, grants, or unusual compensation-related derivatives.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 15,654 | $44.46 | $696K |
| Sale | Ordinary Shares | 791 | $45.00 | $36K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. This transaction was executed in multiple trades at prices ranging from $43.99 to $44.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
